Cloud-Based Drug Discovery Platform Market Trends and Competitive Lan FMI | Page 4

Report Description

Cloud-Based Drug Discovery Platform Market Segmentation

On the basis of types of services, the cloud-based drug discovery platform market is segmented into infrastructure as a Service( IaaS), Platform as a Service( PaaS) and Software as a Service( SaaS). IaaS offers data-center space, and servers, network equipment such as software for businesses and routers / switches. PaaS offers full hardware architecture and software framework. In SaaS process providers allow access to software through online medium only.

Geographically, global cloud-based drug discovery market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America and Western Europe are the leading players in the cloud-based drug discovery platform market. The growth of the market in Asia Pacific is anticipated to witness steady growth over the forecast period.

Cloud-Based Drug Discovery Platform Market Dynamics

Data management is a critical issue for the pharmaceutical industry. The pharmaceutical industry is rapidly restructuring its discovery business model to completely networked and integrated research and development in order to manage the huge data it generates. Storing this data on cloud not only offers cost savings, but also improved accessibility.

Graphical representation, a dynamic and quick form of getting results, helps in decisionmaking at a management level. Keeping the needs of consumers in mind, key players in the cloud-based drug discovery platform are offering flexible, cost-effective, and highly secure cloud-based storage options to consumers.